Omega Therapeutics (OMGA) Expected to Announce Quarterly Earnings on Thursday

Omega Therapeutics (NASDAQ:OMGA) is projected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter.

Omega Therapeutics Trading Down 21.8 %

Omega Therapeutics stock opened at $0.13 on Wednesday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.61 and a current ratio of 1.61. Omega Therapeutics has a fifty-two week low of $0.10 and a fifty-two week high of $3.77. The stock has a market cap of $6.92 million, a P/E ratio of -0.09 and a beta of 1.65. The firm’s fifty day moving average price is $0.25 and its 200-day moving average price is $0.75.

About Omega Therapeutics

Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury.